Crossmark

ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer

Published Online: 2024-12-02

Published Print: 2025-02

Authors

Winer, Leah K.

Williams, Austin D.
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Received: 12 November 2024

Accepted: 12 November 2024

First Online: 2 December 2024

Disclosures

: The authors declare that they have no conflict of interest.

Document is current